University of California-San Francisco · NeuroscienceThe Inclusivity Diagnostics Lab
Gil Dan Rabinovici · San Francisco, California
Research Focus
The research lab led by Dr. Gil Dan Rabinovici at UCSF focuses on improving the diagnosis of Alzheimer's disease and related dementias (ADRD). Their work seeks to validate accessible biomarkers and cognitive tests, particularly for underrepresented populations, to enhance diagnostic precision and inclusivity. Through collaboration with a multi-disciplinary team, they aim to develop scalable approaches to identify individuals who may benefit from disease-modifying therapies.
Alzheimer's Diseasebiomarkerscognitive assessmentsprecision medicinehealth disparitiesneurogenerationneuroimagingdiversity in researchclinical practice
Research Aims
5AIM 01Validate clinical and plasma-based biomarkers for Alzheimer's disease diagnosis.
AIM 02Develop scalable precision medicine tools for diverse populations.
AIM 03Identify health disparities in ADRD diagnosis and care models.
AIM 04Improve diagnostic accuracy for symptomatic cognitive impairment.
AIM 05Foster a mentoring program for early-stage researchers in the field of Alzheimer's research.
Skills the Lab Values
Cognitive testingBlood-based biomarkers analysisBrain imaging techniques (MRI, PET)Clinical trial recruitmentStatistical analysisPatient data managementSurvey design and administrationMentoring opportunities in researchDiversity and inclusion strategies in research
Output against the department
Publications814top 6% of dept.39th of 671
this lab
most publishedleast published
Citations53ktop 6% of dept.41st of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.